Cargando…
Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study
BACKGROUND: Intravenous iron is widely used to control anemia in dialysis patients and limits costs related to erythropoiesis-stimulating agents (ESA). Current guidelines do not clearly set upper limits for serum ferritin (SF) and transferrin saturation (TSAT). International surveys such as the Dial...
Autores principales: | Peters, N. O., Jay, N., Cridlig, J., Rostoker, G., Frimat, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358046/ https://www.ncbi.nlm.nih.gov/pubmed/28320343 http://dx.doi.org/10.1186/s12882-017-0513-x |
Ejemplares similares
-
Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations
por: Rostoker, Guy, et al.
Publicado: (2019) -
Maximal Standard Dose of Parenteral Iron for Hemodialysis Patients: An MRI-Based Decision Tree Learning Analysis
por: Rostoker, Guy, et al.
Publicado: (2014) -
Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study
por: Rostoker, Guy, et al.
Publicado: (2018) -
Options for intravenous iron supplementation in hemodialysis patients
por: Kong, Ji Yoon, et al.
Publicado: (2020) -
Signal-intensity-ratio MRI accurately estimates hepatic iron load in hemodialysis patients
por: Rostoker, Guy, et al.
Publicado: (2017)